Key Takeaways

• Cannabis law and regulations:
  • Germany legalized medical cannabis on January 19th, 2017, allowing patients with qualifying conditions to legally obtain medical cannabis from pharmacies with a doctor’s prescription.
  • On 22 March, 2024, Germany’s upper house approved the Cannabis Act (CanG), consisting of the Consumer Cannabis Act (KCanG) which regulates the adult-use cannabis market, and the Medical Cannabis Act (MedCanG) which collects the regulations on medical cannabis in one law.
  • On July 30, 2026, the Statutory Health Insurance Stabilization Act came into effect, among other things excluding medical cannabis flowers from reimbursement by statutory health insurance. Medical cannabis extracts are still eligible for reimbursement but patients will have to complete a mandatory six-month trial, prescribed by a treating physician, with an approved, finished cannabis-based pharmaceutical product before they can qualify for statutory health insurance coverage.
• Licenses available:
  • Medical cannabis cultivator; medical cannabis dealer; medical cannabis manufacturer; adult-use cannabis cultivation association.
• Products legal:
  • Flowers, liquid cannabis extracts, capsules, sprays, drops.
• Taxes:
  • There is no specific excise tax on cannabis in Germany.
• Market:
  • As of June 2025, an estimated 338,000 people are active medical cannabis patients and together with an additional 500-600 thousand ‘self-paying telemedicine patients’, there are 700-900 thousand cannabis users in Germany.
  • In the first quarter of 2025, Germany imported 37,223 kilograms of medical cannabis – a surge of 357% from the same quarter last year. Exponential growth continued in the next two quarters, reaching 59,442 kilograms in Q3 2025 and then stabilizing, rising to just 60,272 kilograms in Q4. This brought the total 2025 imports to 205,107 kilograms of cannabis dried flower – nearly three times the amount imported in 2024. In Q1 2026, imports jumped again to 67,569 kilograms, indicating that the growth is not yet over.
  • According to the Federal Association of Cannabis Growers, as of August 2026, 455 applications for a cannabis social club license have been approved. There are 225 submitted applications still being reviewed.

Cannabis Legalization in Germany

Medical

On January 19th, 2017, Germany’s parliament (Bundestag) passed a law that officially made cannabis legal for medicinal purposes, allowing for severely ill German patients to receive prescriptions for medical cannabis treatment. This amendment became effective from March 2017, allowing people with qualifying conditions to legally obtain medical marijuana from pharmacies with a doctor’s prescription.

In April 2019, the Federal Institute for Drugs and Medical Devices (BfArM) announced that it was awarding the tender to cultivate cannabis domestically in Germany to three companies exclusively for distribution in German markets. In total, the tender ensures that the BfArM will purchase 10,400 kilograms of cannabis from producers for an estimated wholesale price of €2.3 per gram. 10,400 kilograms is further split into 2,600 kilograms per year between the companies in the proportions listed below:

• Aurora – 1,000kg/year for 4 years
• Tilray – 1,000kg/year for 4 years
• Demecan – 600kg/year for 4 years

The Cannabis Act (CanG), which was approved by Germany’s upper house on 22 March, 2024, consists of the Consumer Cannabis Act (KCanG) and the Medical Cannabis Act (MedCanG). KCanG regulates cultivation of cannabis at home and social cannabis clubs. MedCanG collects the regulations on medical cannabis into one law. It came into force on 1 April 2024. The new law establishes a purely authorization-based procedure instead of an award-based tendering process. New cultivators are able to apply for a license from the BfArM.

From October 17, German doctors who have certain specialist qualifications can prescribe medical cannabis without first receiving approval from statutory health insurance companies.

Previously, medical cannabis used by patients with a serious illness where standard treatment is unavailable or unstable could be covered by the broad health insurance savings package (GKV-Beitragssatzstabilisierungsgesetz). However, on July 30, 2026, the Statutory Health Insurance Stabilization Act came into effect, among other things excluding medical cannabis flowers from reimbursement by statutory health insurance. The reimbursement will still be available for four finished cannabis-based medicines: Sativex, Epidyolex, Canemes, and Exilby (once it enters the reimbursable market; it is currently in the price negotiation stage with the Federal Joint Committee). Patients will have to complete a mandatory six-month trial, prescribed by a treating physician, with an approved, finished cannabis-based pharmaceutical product before they can qualify for statutory health insurance coverage.

Recreational

On February 23, 2024, the Bundestag (the lower house of the German legislature or parliament) passed the Cannabis Act (CanG) legalizing the recreational use of cannabis for personal use in the country. CanG was approved by Germany’s upper house, the Bundesrat, on 22 March, 2024, and came into force on April 1. Provisions regulating cannabis social clubs came into force on July 1, 2024. The first cannabis social club was approved on July 8.

Germany’s approach to the legalization of adult-use cannabis has two pillars. Pillar One involves the removal of cannabis from the German Narcotic Drugs Act (BtMG). This allows individuals to possess up to 25 grams in public and 50 grams at home. It also allows up to three plants per person to be grown at home and creates cannabis social clubs that will have up to 500 members, from which individuals can obtain up to 50 grams of cannabis per month.

Regulations for Pillar Two, which is meant to provide regional model projects for commercial cultivation and sale of recreational cannabis, have not yet been developed. Only cannabis flowers and hash (solventless derivatives) can be distributed.

German Cannabis Market: Stats and Perspectives

Domestic Market: Consumers & Licensees

A 2021 survey found that around 7 million Germans have reportedly consumed cannabis at least once in a 12-month period. Four million people used cannabis in Germany in 2022, and a quarter of all people aged 18 to 24 in the country used it, according to the Minister of Health. As of February 2024, this number had increased to 4.5 million.

In 2022 over 170,000 patients were prescribed medical cannabis in Germany comparing to about 128,000 patients in 2020, 60,000 patients in 2019 and 40,000 patients in 2018. In April 2024, Germany had around 250,000 medical cannabis patients. As of June 2025, an estimated 338,000 people were active medical cannabis patients. However, the rise of telemedicine clinics has created a new category of ‘self-paying telemedicine patients’ who use medical cannabis for self-medication or adult-use purposes and it is estimated that there could be between 500-600 thousand ‘self-paying telemedicine patients’, bringing the total patient number to 700-900 thousand patients.

In July 2024, Tilray’s Aphria RX Facility in Germany was granted a new cannabis cultivation license after the passing of MedCanG. The new license allows to increase production by five times and add 31 new strains. Two other companies, Aurora and Demecan, have also received new licenses and expanded cultivation permits under the new law.

According to the Business of Cannabis, around 2,500 to 3,000 pharmacies currently dispense medical cannabis. Meanwhile, the number of specialized cannabis pharmacies increased fivefold from around 50 in April 2024 to more than 250 in April 2025.

How to Start a Cannabis Business in Germany?

Between July and August, there was a 237% increase in the total number of confirmed applications for cannabis social clubs in Germany. From August to September, the percentage increase was lower at 34%, from 206 applications in August to 303 applications in September. As of July 19, 2025, authorities had approved 293 cannabis social clubs. According to the Federal Association of Cannabis Growers, as of August 2026, 455 applications for a cannabis social club license have been approved. There are 225 submitted applications still being reviewed.

Imports of Cannabis into Germany

The German group Cansativa holds the sole license to distribute medical cannabis to German pharmacies, which they started doing in July 2021 after purchasing the product from three companies cultivating cannabis domestically: Aurora Cannabis, Tilray and Demecan. While domestic producers may exceed the declared amount by 10%, 2600 kg per year does not cover the needs of Germany. Imports to Germany have been increasing steadily since the inception of the market in 2017; they almost doubled each year on average up to the end of 2021. The total volume of cannabis imported into Germany in 2023 was 32,493 kilograms: a 30.6% increase from the 24,875 kilograms imported in 2022. From 2023 to 2024, Germany’s imports of medical cannabis more than doubled to reach 72,850 kilograms. Canada accounted for 45.5% of the 2024 imports, making it the largest supplier of cannabis into Germany. It is followed by Portugal (23.7%) and Denmark (10.2%).

How to Export Medical Cannabis to Europe?

According to a report by the Prohibition Partners, since the passing of the CanG Act, there was a particularly sharp increase in imports from around 8,143 kilograms in Q1 2024 to 11,634 kilograms in Q2 2024: a 43% rise. By Q4 2024, cannabis imports increased almost fourfold (BfArM) from Q1 2024 to 32,419 kilograms. In the first quarter of 2025, Germany imported 37,223 kilograms of medical cannabis – a surge of 357% from the same quarter last year and a 15% rise from the previous quarter. Exponential growth continued in the next two quarters, reaching 59,442 kilograms in Q3 2025 and then stabilizing, rising to just 60,272 kilograms in Q4. This brought the total 2025 imports to 205,107 kilograms of cannabis dried flower: nearly three times the amount imported in 2024. In Q1 2026, imports jumped again to 67,569 kilograms, indicating that the growth is not yet over.

Canada and Portugal are the largest suppliers of cannabis flower into Germany. In 2024 and 2025, Canada accounted for around 45% of the total imported volume. Meanwhile, Portugal contributed 24% of the 2024 imports and around 27% of the 2025 imports. Other notable exporters include Denmark (4.5% of 2025 imports), North Macedonia (4%), and Spain, the Czech Republic, and Malta which each accounted for around 2.3%.

Exports of Cannabis from Germany

Germany also exports some of its domestically produced cannabis dried flowers and extracts. Exports of dried cannabis flower from Germany reached 7,429 kilograms in 2024 – nearly double the amount exported in 2022. However, in 2025, they fell slightly to 6,389 kilograms.

Estimated Market Value

Industry analysts project Germany’s medical cannabis sales – which were valued at around €420 million in 2024 and surpassed €900 million in 2025 – could exceed €1 billion by 2027. The anticipated launch of a regulated recreational market (Phase Two) is expected to drive further growth.

Source: cannabusinessplans.eu

German Cannabis Market Infographics

German Hemp CBD Industry